Yokohama, Japan

Kenichi Umishio



Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Kanagawa, JP (2000 - 2001)
  • Yokohama, JP (1993 - 2017)

Company Filing History:


Years Active: 1993-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kenichi Umishio: Innovator in Artificial Skin Technology

Introduction

Kenichi Umishio is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the development of artificial skin. With a total of eight patents to his name, Umishio's work has the potential to impact medical treatments and improve the quality of life for many individuals.

Latest Patents

Among his latest innovations is a method for producing artificial skin. This invention involves adding a matrix metalloproteinase inhibitor and a heparanase inhibitor to an artificial skin formation culture medium that comprises human epidermal keratinocytes and human dermal fibroblasts. The process includes culturing the cells in this specialized medium to successfully form artificial skin. This advancement represents a significant step forward in regenerative medicine.

Career Highlights

Kenichi Umishio is currently associated with Shiseido Company, Limited, where he continues to push the boundaries of innovation in skin technology. His expertise and dedication to research have led to numerous advancements in the field, making him a respected figure among his peers.

Collaborations

Umishio has worked alongside notable colleagues such as Koji Kobayashi and Hirotada Fukunishi. Their collaborative efforts have contributed to the success of various projects and have fostered a culture of innovation within their organization.

Conclusion

Kenichi Umishio's work in artificial skin technology exemplifies the spirit of innovation and dedication to improving human health. His contributions through patents and collaborations highlight the importance of research in advancing medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…